Corvus Pharmaceuticals, Inc. (CRVS) stock
CRVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$10.17−0.43 (-4.06%)
Close on Nov 17, 2026Market cap $855.51MP/E –Yield –
Corvus Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Corvus Pharmaceuticals's market cap was $964.87M on Nov 11, 2026, against $684.83M a year earlier. Over the last 5 years it ranged from $33.98M to $1.55B, with a median of $126.03M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $964.87M | +67.8% |
| 2025 | Dec 31, 2025 | $575.05M | +71.8% |
| 2024 | Dec 31, 2024 | $334.80M | +287.9% |
| 2023 | Dec 29, 2023 | $86.31M | +118.1% |
| 2022 | Dec 30, 2022 | $39.57M | -64.7% |
| 2021 | Dec 31, 2021 | $112.18M | +12.3% |
| 2020 | Dec 31, 2020 | $99.89M | -37.6% |
| 2019 | Dec 31, 2019 | $159.97M | +48.9% |
| 2018 | Dec 31, 2018 | $107.47M | -50.5% |
| 2017 | Dec 29, 2017 | $216.98M | -27.4% |
| 2016 | Dec 30, 2016 | $299.04M | – |
See a number that looks wrong?